bioRxiv / medRxiv
open access
CC BY 4.0
Pharmacovigilance of Integrase Strand Transfer Inhibitors (INSTIs) in Botswana: Safety Signals, Report Completeness, and Causality Assessment
Integrase strand transfer inhibitors (INSTIs) are the preferred first-line anchor drug for antiretroviral therapy globally. However, post-marketing authorisation studies continue to find previously unidentified adverse events (AEs) associated with INSTIs. A pharmacovigilance study was conducted to i
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults#1140715
- Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects#1139307
- Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV#1323627
- IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)#1198138
- Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection#1059926
Record · ID 1258117
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive